PDF (1288K)
摘要
高血压是全球最常见的慢性非传染性疾病之一,其患病率持续上升,对无偿献血人群结构与血液供应安全产生重要影响。高血压人群能否安全献血及其筛查管理策略,长期以来在输血医学领域存在争议。本文系统综述了高血压的流行病学特征、献血相关生理变化及潜在风险机制,并整合国际多中心研究证据与部分国家管理实践,对高血压人群献血的安全性与准入标准进行了综合分析。现有研究表明,在血压控制稳定、无严重心脑肾并发症及靶器官损伤的前提下,高血压人群献血后不良反应发生率与健康人群总体相当,血压水平与血管迷走反应之间未显示明确相关性。当前国际主流管理模式逐步由基于单一血压阈值的筛查,转向“风险分级与个体化动态评估”相结合的策略,重点关注血压长期控制情况、药物使用稳定性及并发症状态。与此同时,人工智能、动态血压监测及可穿戴设备等新兴技术为献血风险评估与全过程管理提供了新的技术路径。基于现有证据,未来应进一步完善多维风险分层体系,推动智能化筛查与连续监测技术的应用,并加强高血压人群的健康宣教与随访管理,以在保障献血安全的前提下合理扩大合格献血者来源,从而实现血液安全与供给能力的协同提升。
Abstract
Hypertension ranks among the most prevalent chronic non-communicable diseases worldwide, with its prevalence rising steadily and exerting substantial impacts on the demographic composition of voluntary blood donors and the safety of blood supply. The eligibility of hypertensive individuals for safe blood donation and the relevant screening and management strategies have long remained controversial in transfusion medicine. This article systematically reviews the epidemiological characteristics of hypertension, donation-related physiological alterations and underlying risk mechanisms. By synthesizing evidence from international multicenter studies and regulatory practices across major nations, it conducts a comprehensive analysis of blood donation safety and donor admission criteria for hypertensive patients. Available evidence demonstrates that for hypertensives with well-stabilized blood pressure and no severe cardiac, cerebral or renal complications or target organ damage, the overall incidence of adverse reactions following blood donation is comparable to that in healthy donors, and no definitive correlation has been identified between blood pressure levels and vasovagal responses. Current mainstream international management frameworks are gradually shifting from screening reliant on a single blood pressure cutoff value toward an integrated strategy combining stratified risk classification and individualized dynamic assessment, with core focus on long-term blood pressure control, consistency of medication regimens and complication status. Meanwhile, emerging technologies including artificial intelligence, ambulatory blood pressure monitoring and wearable devices have opened innovative avenues for blood donation risk evaluation and full-cycle donor management. In light of existing clinical evidence, future efforts should further refine the multi-dimensional risk stratification system, facilitate the implementation of intelligent screening and continuous monitoring technologies, and scale up health education and follow-up management for hypertensive populations. Such measures aim to appropriately expand the pool of eligible blood donors while safeguarding donation safety, ultimately achieving coordinated improvement in blood safety and blood supply capacity.
关键词
Key words
[Author(id=1329094221576110153, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=Lizhouzhaogg@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329094221643219019, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094221576110153, language=EN, stringName=Lizhou ZHAO, firstName=Lizhou, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094221693550670, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094221576110153, language=CN, stringName=赵丽洲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio={"content":"赵丽洲(1996-),男,技师,Email:Lizhouzhaogg@163.com
"}, bioImg=null, bioContent=赵丽洲(1996-),男,技师,Email:Lizhouzhaogg@163.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])]), Author(id=1329094221743882323, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329094221810991190, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094221743882323, language=EN, stringName=Meng LI, firstName=Meng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094221861322840, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094221743882323, language=CN, stringName=李萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])]), Author(id=1329094221911654493, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329094221978763364, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094221911654493, language=EN, stringName=Ying LI, firstName=Ying, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094222029095014, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094221911654493, language=CN, stringName=李莹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])]), Author(id=1329094222083620971, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329094222159118448, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222083620971, language=EN, stringName=Xue CHEN, firstName=Xue, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094222209450101, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222083620971, language=CN, stringName=陈雪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])]), Author(id=1329094222263976058, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329094222331084928, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222263976058, language=EN, stringName=Kefen WANG, firstName=Kefen, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094222381416580, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222263976058, language=CN, stringName=王克芬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])]), Author(id=1329094222435942537, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329094222503051406, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222435942537, language=EN, stringName=Yishu WANG, firstName=Yishu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094222553383059, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222435942537, language=CN, stringName=王一淑, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])]), Author(id=1329094222607909016, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, orderNo=6, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuemeifucdbc@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329094222675017886, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222607909016, language=EN, stringName=Xuemei FU, firstName=Xuemei, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chengdu Blood Center, Chengdu 6111020,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329094222725349538, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, authorId=1329094222607909016, language=CN, stringName=傅雪梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=成都市血液中心,四川 成都 610020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329094221492224069, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, xref=null, ext=[AuthorCompanyExt(id=1329094221509001286, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chengdu Blood Center, Chengdu 6111020,China), AuthorCompanyExt(id=1329094221525778503, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329080930677695097, companyId=1329094221492224069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=成都市血液中心,四川 成都 610020)])])]
赵丽洲,李萌,李莹,陈雪,王克芬,王一淑,傅雪梅.
高血压人群献血:风险机制、国际实践与未来展望[J].
中国输血杂志, 2026, 39(6): 799-808 DOI:10.13303/j.cjbt.issn.1004-549x.2026.06.015
| [1] |
GELDSETZER P, MANNE-GOEHLER J, MARCUS M E, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults[J].Lancet (London, England), 2019, 394(10199):652-662.
|
| [2] |
World Health Organization. WHO Global report on hypertension 2025-High stakes: turning evidence into action[EB/OL].(2025-09-23)[2026-06-02]. https://www.who.int/publications/i/item/9789240115569.
|
| [3] |
FARRAR J, FRIEDEN T. WHO global report on hypertension 2025[J].The Lancet, 2025, 406 (10517): 2318-2319.
|
| [4] |
JACOBS J W, BATES I, M′BAYA B, et al. Ensuring a safe and sufficient global blood supply[J].The New England journal of medicine, 2024, 391 (12): 1079-1081.
|
| [5] |
LIU Y, PAN Y, ZHENG Z, et al. Impact of shifting blood donation policy from gift to honour model: staggered difference-in-differences analysis in China[J].BMJ (Clinical research ed), 2026, 392:e084999.
|
| [6] |
PAGNESI M, RICCARDI M, SACCO A, et al. Pre-admission beta-blocker therapy and outcomes in cardiogenic shock:Insights from the Altshock-2 Registry[J].ESC heart failure, 2025, 12(4):2565-2577.
|
| [7] |
SNEDDEN W, FERNANDEZ P G, VASDEV S, et al. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives[J].The Canadian journal of cardiology, 1989, 5(1):37-41.
|
| [8] |
WHELTON P K, CAREY R M, ARONOW W S, et al. 2017 ACC/ AHA/ AAPA/ ABC/ ACPM/ AGS/ APhA/ ASH/ ASPC/ NMA/ PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/ American Heart Association Task Force on Clinical Practice Guidelines[J].Journal of the American College of Cardiology, 2018, 71(19):e127-e248.
|
| [9] |
Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology:ESH/ ESC Task Force for the Management of Arterial Hypertension:Erratum[J]. Journal of hypertension, 2019, 37(2):456.
|
| [10] |
WANG Z, CHEN Z, ZHANG L, et al. Status of hypertension in china:results from the china hypertension survey, 2012-2015[J].Circulation, 2018, 137 (22): 2344-2356.
|
| [11] |
O′CONNELL S, WHELTON P, HE H, et al. Abstract MP12:global disparities of hypertension prevalence and control:a systematic analysis of population-based studies[J].Circulation, 2025, 151(Suppl_1).
|
| [12] |
MOLORO A H, SEID A A, JALETA F Y . A systematic review and meta-analysis protocol on hypertension prevalence and associated factors among bank workers in Africa[J]. SAGE open medicine, 2023, 11: 20503121231172001.
|
| [13] |
MAHATARA E, MOHAMED F, TEFERI H, et al. Strategies to curb the rising burden of hypertension in sub-Saharan Africa:insights from the WHO global hypertension report 2025[J].Journal of hypertension, 2026, 44(4):575-578.
|
| [14] |
NWANKWO M, MAKENA W, IDRIS A, et al. Hypertension in West Africa:a systematic review and meta-analysis of prevalence and associated risk factors[J].BMC public health, 2025, 25(1):3269.
|
| [15] |
NIU C, ZHANG P, WEI L, et al. The global burden of hypertension and its epidemiological impacts on adolescents and young adults:projections to 2050[J].Front Cardiovasc Med,2025,12:1619445.
|
| [16] |
REA F, SAVARé L, FRANCHI M, et al. Adherence to treatment by initial antihypertensive mono and combination therapies[J].American journal of hypertension, 2021, 34(10):1083-1091.
|
| [17] |
ATTAEI M W, KHATIB R, MCKEE M, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries:an analysis of the PURE study data[J].The Lancet Public health, 2017, 2(9):e411-e419.
|
| [18] |
MORAN A E, SAHOO S K, BANIGBE B, et al. Calcium channel blockers:key medicine to drive global hypertension control[J].Global heart, 2025, 20(1):61.
|
| [19] |
MURPHY A, MBUTHIA D, WILLIS R, et al. Improving implementation of NCD care in low-and middle-income countries:the case of fixed dose combinations for hypertension in Kenya[J].Health systems and reform, 2025, 11(1):2448862.
|
| [20] |
METZ M, SUFRA R, OGYU A, et al. Improvements in blood pressure control and the hypertension care continuum over 2 years in urban Haiti Amidst Civil Unrest[J].Journal of clinical hypertension (Greenwich, Conn), 2025, 27(9):e70153.
|
| [21] |
CHERAGHI Z, AZMI-NAEI B, CHERAGHI P, et al. The global prevalence of uncontrolled hypertension: a systematic review and meta-analysis[J].BMC public health, 2025, 25(1):4259.
|
| [22] |
SHIN D, CHOI J, LEE H Y. Suboptimal control status of young hypertensive population[J].Clinical hypertension, 2023, 29(1):13.
|
| [23] |
ALEXANDER T J, GAUEN A M, PETITO L C, et al. Hypertension in young adults: social determinants of prevalence, awareness, treatment, and control[J].American journal of hypertension, 2026, 39 (3): 425-431.
|
| [24] |
FENG W, YUN W, LE W, et al. The influence of demographic and lifestyle factors on blood donation delay among student population: a retrospective study[J]. Frontiers in public health, 2023, 11:1297472.
|
| [25] |
AGNIHOTRI N. Whole blood donor deferral analysis at a center in Western India[J].Asian journal of transfusion science, 2010, 4(2):116-122.
|
| [26] |
SCHUTTE A E, SRINIVASAPURA VENKATESHMURTHY N, MOHAN S, et al. Hypertension in Low-and Middle-Income Countries[J]. Circulation research, 2021, 128(7):808-826.
|
| [27] |
FORTRAT J O, NASR O, DUVAREILLE M, et al. Human cardiovascular variability, baroreflex and hormonal adaptations to a blood donation[J].Clinical science (London, England:1979), 1998, 95(3):269-275.
|
| [28] |
ZöLLEI É, PAPRIKA D, MAKRA P, et al. Human autonomic responses to blood donation[J].Autonomic Neuroscience, 2004, 110(2):114-120.
|
| [29] |
GILCHRIST P T, DITTO B. Sense of impending doom: Inhibitory activity in waiting blood donors who subsequently experience vasovagal symptoms[J].Biological Psychology, 2015, 104:28-34.
|
| [30] |
YAZDANI B, YüCEL G, SCHULZ K, et al. Changes in central and peripheral hemodynamic parameters during blood donation[J].Frontiers in cardiovascular medicine, 2025, 12:1628366.
|
| [31] |
NICIA S B, VAN VEELEN T A, STENS J, et al. Detection of volume loss using the Nexfin device in blood donors[J].Anaesthesia, 2016, 71(2):163-170.
|
| [32] |
IZZO J L, Jr. , TAYLOR A A. The sympathetic nervous system and baroreflexes in hypertension and hypotension[J].Current hypertension reports, 1999, 1(3):254-263.
|
| [33] |
ZöLLEI E, PAPRIKA D, MAKRA P, et al. Human autonomic responses to blood donation[J]. Autonomic neuroscience: basic & clinical,2004, 110 (2): 114-120.
|
| [34] |
ROTHWELL P M, HOWARD S C, DOLAN E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension[J].Lancet (London, England), 2010, 375(9718): 895-905.
|
| [35] |
TALISHINSKY A, AJIJOLA O A, KHALSA S S . Autonomic imbalance in cardiomyopathy and heart failure: from neurobiology to precision neuromodulation[J]. Current cardiology reports, 2025, 27(1):144.
|
| [36] |
PATEL M, BRAUN J, LAMBERT G, et al. Central mechanisms in sympathetic nervous dysregulation in obesity[J].Journal of neurophysiology, 2023, 130 (6): 1414-1424.
|
| [37] |
WILLIE C K, TZENG Y C, FISHER J A, et al. Integrative regulation of human brain blood flow[J].The Journal of physiology, 2014, 592(5):841-859.
|
| [38] |
XING C Y, TARUMI T, MEIJERS R L, et al. Arterial pressure, heart rate, and cerebral hemodynamics across the adult life span[J].Hypertension (Dallas, Tex: 1979), 2017, 69(4):712-720.
|
| [39] |
THORPE R, MASSER B, COUNDOURIS S P, et al. The health impacts of blood donation:a systematic review of donor and non-donor perceptions[J].Blood transfusion = Trasfusione del sangue, 2024, 22(1):7-19.
|
| [40] |
WEISBACH V, SCHNABEL L, ZIMMERMANN R, et al. A pilot study of continuous ambulatory monitoring of blood pressure in repeated preoperative autologous blood donation[J].Transfusion, 2006, 46(6):934-941.
|
| [41] |
KARIO K, MATSUO T, KOBAYASHI H, et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers[J].Hypertension (Dallas, Tex:1979), 1996, 27(1):130-135.
|
| [42] |
KARIO K, PICKERING T G, MATSUO T, et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives[J].Hypertension (Dallas, Tex: 1979), 2001, 38(4):852-857.
|
| [43] |
STAINSBY D, BRUNSKILL S, CHAPMAN C E, et al. Safety of blood donation from individuals with treated hypertension or non-insulin dependent type 2 diabetes -a systematic review[J].Vox sang, 2010, 98(3 Pt 2): 431-440.
|
| [44] |
World Health Organization Blood donor selection:guidelines on assessing donor suitability for blood donation. World Health Organization, Geneva, 2012[J].
|
| [45] |
Health Sciences Authority. Check the criteria that may affect your eligibility to donate blood[EB/OL].(2026-05-25)[2026-6-2]. https://www.hsa.gov.sg/blood-donation/can-i-donate.
|
| [46] |
NISSEN-MEYER L S H, SEGHATCHIAN J . Donor health assessment -When is blood donation safe?[J].Transfusion and apheresis science:official journal of the World Apheresis Association:official journal of the European Society for Haemapheresis, 2019, 58 (1): 113-116.
|
| [47] |
JOHNSEN K M N, MAGNUSSEN K, ERSTAD C, et al. Safe blood donation from donors using antihypertensive medication. a multi-center retrospective quality study from south-east Norway[J].Journal of blood medicine, 2023, 14:337-343.
|
| [48] |
PISCIOTTO P, SATARO P, BLUMBERG N . Incidence of adverse reactions in blood donors taking antihypertensive medications[J].Transfusion, 1982, 22 (6):530-531.
|
| [49] |
BUDAKOV OBRADOVIC Z, LAZAREVIC S, DANIC M, et al. Antihypertensive drugs in blood donations in Serbia -Observational study[J].Transfusion and apheresis science:official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis, 2023, 62(6):103790.
|
| [50] |
WU Y, QI H, DI ANGELANTONIO E, et al. Risk factors for vasovagal reactions in blood donors:A systematic review and meta-analysis[J].Transfusion, 2025, 65 (1):211-223.
|
| [51] |
TROUERN-TREND J J, CABLE R G, BADON S J, et al. A case-controlled multicenter study of vasovagal reactions in blood donors:influence of sex, age, donation status, weight, blood pressure, and pulse[J].Transfusion, 1999, 39(3):316-320.
|
| [52] |
EDER A F, HILLYER C D, DY B A, et al. Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds[J].Jama, 2008, 299(19):2279-2286.
|
| [53] |
LEWINGTON S, CLARKE R, QIZILBASH N, et al. Age-specific relevance of usual blood pressure to vascular mortality:a meta-analysis of individual data for one million adults in 61 prospective studies[J].Lancet (London, England), 2002, 360(9349):1903-1913.
|
| [54] |
World Health Organization. Blood donor selection:guidelines on assessing donor suitability for blood donation. (2012-05)[2026-06-02]. https://www.ncbi.nlm.nih.gov/books/NBK138205/.
|
| [55] |
FDA. Blood pressure and pulse donor eligibility requirements -compliance policy[S/OL].(2024-07-01)[2026-06-02]. https://www.fda.gov/vaccines-blood-biologics/guidance-complianceregulatory-information-biologics/biologics-guidances.
|
| [56] |
DONALD S J, MCINTYRE W F, DINGWALL O, et al. Is donating blood for the faint of heart? a systematic review of predictors of syncope in whole blood donors[J].Transfusion, 2019, 59(9):2865-2869.
|
| [57] |
SALVADORI U, SANDRI M, CEMIN R, et al. Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions[J].Vox sang, 2019, 114(4):317-324.
|
| [58] |
GERMAIN M, DELAGE G, GRéGOIRE Y, et al. Donation by donors with an atypical pulse rate does not increase the risk of cardiac ischaemic events[J].Vox sanguinis, 2013, 104(4):309-316.
|
| [59] |
EDER A. Evidence-based selection criteria to protect blood donors[J].Journal of clinical apheresis, 2010, 25(6):331-337.
|
| [60] |
PAUWELS N S, CUSACK L, DE BUCK E, et al. The effect of pre-donation hypotension on whole blood donor adverse reactions:a systematic review[J].Journal of the American Society of Hypertension:JASH, 2014, 8(6): 429-436.
|
| [61] |
EDQM. Guide to the preparation,use and quality assurance of blood components[M]. 22th ed. Strasbourg: EDQM,2025:307[J].
|
| [62] |
Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Blood pressure, high[S/OL].(2024-10-07)[2026-06-02]. https://www.transfusionguidelines.org/dsg/wb/guidelines/bl005-blood-pressure-high.
|
| [63] |
COGNASSE F, AVRIL S, FLECK J L, et al. Artificial Intelligence in transfusion medicine:a paradigm shift on the horizon[J].Blood transfusion = Trasfusione del sangue, 2025, 23(6):558-561.
|
| [64] |
BADAWI M A. Artificial intelligence in blood donor management:A narrative review[J].Vox sanguinis, 2025.
|
| [65] |
浙江省血液中心. 全生命周期视角下基于人工智能技术的固定成分献血 mHealth 系统的构建及应用[EB/OL].(2025-04-15)[2026-06-02]. https://www.zjb.org.cn/index.php?s=/Home/Women/psp_detail/id/6329.html.
|
| [66] |
Zhejiang Blood Center. Construction and application of an mHealth system for regular apheresis donation based on artificial intelligence from a full-life-cycle perspective[EB/OL].(2025-04-15)[2026-06-02]. https://www.zjb.org.cn/index.php?s=/Home/Women/psp_detail/id/6329.html.
|
| [69] |
HELGESON E S, VEMPATI S, PALZER E F, et al. Development and validation of a hypertension risk calculator for living kidney donors[J]. Transplantation, 2023, 107(6):1373-1379.
|
| [70] |
CROWDER L A, EDER A F, STEELE W R. Effectiveness of the post-donation instruction sheet in conveying information to repeat blood donors[J].Vox sanguinis, 2021, 116(3):305-312.
|
| [71] |
FRANCE C R, FRANCE J L, HIMAWAN L K, et al. Results from the blood donor competence, autonomy, and relatedness enhancement (blood donor CARE) randomized trial[J].Transfusion, 2021, 61 (9): 2637-2649.
|
| [72] |
FRANCE C R, FRANCE J L, KOWALSKY J M, et al. Education in donation coping strategies encourages individuals to give blood:further evaluation of a donor recruitment brochure[J].Transfusion, 2010, 50(1):85-91.
|
| [73] |
杨锦, 孙莉, 毕岐勇, et al. 献血者初筛体检血压异常导致暂缓献血及返回献血影响因素分析[J].中国输血杂志, 2026, 39(1):56-61.
|
| [74] |
YANG J, SUN L,BI Q,et al. Analysis of factors influencing temporary deferral and return to donation due to abnormal blood pressure in pre-donation screening[J].Chin J Blood Transfusion, 2026,39(1):56-61.
|
| [75] |
DITTO B, ADLER P S, FRANCE C, et al. Family history of hypertension and vasovagal symptoms during blood donation[J].Journal of behavioral medicine, 1995, 18 (4):331-340.
|
| [76] |
THIBEAULT C, LEWIN A, RABUSSEAU I, et al. Deferring blood donors with out-of-range blood pressure: Does it decrease the risk of adverse reactions?[J].Transfusion, 2025, 65(6):1083-1091.
|
基金资助
中国预防医学会2025年血液安全科研项目(YFYXH-2025-XYAQ-1)(YFYXH-2025-XYAQ-1)